Hydroxychloroquine in obstetric antiphospholipid syndrome: rationale and results of an observational study of refractory cases
J. Kh. Khizroeva(Sechenov University), Tamara Mashkova(Sechenov University), К. N. Grigoreva(Sechenov University), В. И. Цибизова(Federal Almazov North-West Medical Research Centre), Z.K. Gadaeva(Sechenov University), M. V. Tretyakova(Sechenov University), I. V. Khamani(Sechenov University), N. N. Babaeva(Sechenov University), В. О. Бицадзе(University of Rome Tor Vergata), Z. D. Aslanova(Sechenov University), Anǵela Tincani(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), А. Г. Солопова(Sechenov University), I. A. Nakaidze(Sechenov University), M. O. Arslanbekova(Sechenov University), А. D. Makatsariya(Sechenov University), Елена Егорова(Sechenov University), Natalya Makatsariya(Sechenov University), Alexander Mischenko(Sechenov University), A. V. Vorobеv(Sechenov University), Andrei S. Shkoda, Nart Kunesko(Scientific Center of Family Health Problems and Human Reproduction)
Cited by 15
Related Papers
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
|Journal of Thrombosis and Haemostasis|2006|7.1k
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS)
|Annals of the Rheumatic Diseases|2016|355